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Abstract
Background: The main objective of this study is to examine the epidemiology of Chlamydia
trachomatis (CT) infection amongst patients (473 men, 180 women) seen two hospitals in Taiwan.
Methods: Between July 2004   and June 2005, a total of 653 patients provided first-void urine
samples for examination of CT using PCR assay.
Results: The overall prevalence of CT infection was 18.4% (95% confidence interval [CI] 17.3–
19.5). Prevalence for men and women were 16.7 % (95% CI 15.3–18.0%) and 22.8% (95% CI 17.5–
28.1%), respectively. Age group-specific prevalence was 25.7% (95% CI 22.5–28.9%) in < 20 year
olds, 23.5% (95% CI 20.3–26.7%) in 20–24 year olds, 22.3% (95% CI 18.9–25.7%) in 25–30 year olds,
and 11.5% (95% CI 10.3–12.7%) in > 30 year olds. Independent risk factors for chlamydial infection
included younger age (aged ≤ 30 years) (adjusted odds ratio [AOR] = 2.44; 95% CI 1.52–3.84; p <
0.001), inconsistent condom use (AOR = 2.01; 95% CI 1.32–3.06; p < 0.001), being symptomatic
(dysuria, urethral discharge) at the time of testing (AOR = 1.84; 95% CI 1.21–2.80; p < 0.001), and
having N. gonorrhoeae infection (AOR = 3.82; 95% CI 2.20–6.58; p < 0.001).
Conclusion: Genital chlamydial infection is an important sexually transmitted disease in Taiwan.
Young Taiwanese persons attending a STD clinic s h o u l d  b e  s c r e e n e d  f o r  C T  i n f e c t i o n  a n d
counselled on condom use.
Background
Young, sexually active people are at high risk for genital
infection by Chlamydia trachomatis (CT) [1,2]. It is esti-
mated that 340 million new cases of common bacterial
and protozoal sexually transmitted infections occur annu-
ally worldwide [3]. An increase in sexually risky behaviour
amongst young people and an associated subsequent
increase in the prevalence of CT have been reported [4,5].
Chlamydial infections can cause severe complications in
untreated infected women such as pelvic inflammatory
diseases (PID), ectopic pregnancy, tubal infertility and
abdominal pain [6]. Serious sequelae among men with
untreated infection include urethritis, prostatitis, epidi-
dymitis and Reiter syndrome [6]. Active CT infection is an
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important risk factor facilitating sexual transmission of
HIV infection [7]. Most women (> 50%) infected with CT
remain symptom-free, and for men, the rate of asympto-
matic chlamydia infection is higher than for symptomatic
gonorrhea infection [8-10]. Early diagnosis and early
treatment of affected individuals are the types of strategies
necessary to prevent the development of sequelae and to
reduce transmission [6]. In Taiwan, although the inci-
dence and prevalence of CT infection is rising [11], only
limited information is available. The aim of this study was
therefore to examine the epidemiology of genital chlamy-
dia infection amongst patients attending STD and geni-
tourinary clinics in Taiwan.
Methods
Patients
The pool of patients included all patients attending two
outpatient clinics between July 2004 and June 2005; one
group was investigated at the Taipei City STD Control
Center clinic (northern Taiwan) and another group was
studied at genitourinary outpatient clinic at a Kaohsiung
primary care service (southern Taiwan).
Taipei and Kaohsiung are two large metropolitan areas in
Taiwan. Only those patients who met the following crite-
ria were included for study: aged> 17 years, sexually active
(reported to have sexual intercourse in the last 60 days)
provided a urine specimen and no antibiotic use in the
preceding 15 days. Approval was obtained from the Ethics
Committee of Taipei City STD Control Center. After sign-
ing an informed consent form, patients were given a self-
administered questionnaire regarding limited demo-
graphic information, symptoms of urethritis (dysuria,
urethral discharge) and condom use during the last inter-
course.
A patient was classified as "symptomatic" if the patient
reported having one of the symptoms (dysuria, urethral
discharge) and as "non-symptomatic" if neither of these
symptoms were reported.
Subsequently, a genital examination was performed by a
doctor and blood samples were tested for Treponema palli-
dum and HIV antibodies. Each participant provided a first
void urine specimen that was tested for CT, Neisseria gon-
orrhoeae, and Trichomonas vaginalis. Those individuals who
had a positive result for the test were informed of this out-
come by a personal telephone call, at which time a medi-
cal appointment was scheduled at the STD clinic for both
the patient and partner(s).
HIV serodiagnosis and STD diagnosis
The Amplicor PCR test for Chlamydia trachomatis/Neisseria
gonorrhoeae (PCR Roche Diagnostic Corp, Indianapolis,
IN, USA) was performed on all individual samples accord-
ing to the manufacturer's instructions for processing urine
specimens [12]. To diagnose T. vaginalis, wet-mount
microscopy and culture in Whittington media (HiMedia
Laboratories, Mumbai, India) were performed on urine
specimens. The Amplicor positive urine samples were
stored at -20°C for further analysis. The Rapid Plasma
Reagin (RPR; Spinreact, Girona, Spain) or the Venereal
Disease Research Laboratory (VDRL) tests were used for
syphilis screening [13], with confirmation by the T. Palli-
dum  haemagglutination assay (TPHA; Gesellschaft fur
Biochemica and Diagnostica, Wiesbaden, Germany) fol-
lowing the manufacturer's instructions. Sera positivity by
both the RPR/VDRL test (at 1:8 dilution) and the TPHA
test were considered to be indicative of active syphilis. For
HIV detection, the double-ELISA test (Biosign kits, Princ-
eton BioMeditech, Princeton, NJ, USA) and western blot
assays (Genelabs Diagnostic, Redwood City, CA, USA)
were performed.
Statistical analysis
For analysis, chlamydial infection was defined as a urine
sample that was positive by the diagnostic Amplicor PCR
test. Statistical analysis was conducted using SPSS soft-
ware for Windows (version 10.0; SPSS). The prevalence of
genital chlamydia infection was calculated with 95% con-
fidence intervals. All variables were analyzed using the
Chi-square test or Fisher's exact test for categorical varia-
bles. All variables that revealed significant results in the
context of univariate analysis were subsequently entered
stepwise into a multiple logistic regression analysis proce-
dure, for which all measured effects were controlled for by
means of controlling the influence of all other variables at
the time of testing. Significance was defined by an alpha
level of 0.05 or less.
Results
Characteristics of all patients
During the period from July 2004 to June 2005, a total of
687 patients were eligible for the study. Among these, 653
(95.1%) patients met the inclusion criteria and were
enrolled the study. The characteristics of the study popu-
lation are indicated in Table 1. The age of study patients
ranged from 17 to 50 years and the median age was 28
years. Seventy-two percent were males and 28% were
females. The most-common age group was ≤ 30 years old
(55%); 75% were single and 25% were married; the prev-
alence of CT among symptomatic patients was 23%; 49%
were symptomatic at the time of testing (dysuria or dis-
charge); 45% not always using condoms during sexual
intercourse; 90% were heterosexual and 10.0% were
homosexual/bisexual.
Of the 653 samples, the prevalences of C. trachomatis, N.
gonorrhoeae, T. Pallidum, HIV, and T. Vaginalis infection
were 18.4% (120/653), 11.2% (73/473), 5.7% (37/653),BMC Public Health 2007, 7:120 http://www.biomedcentral.com/1471-2458/7/120
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1.2% (8/653) and 0.9% (6/653), respectively. No patho-
gens were identified in urine obtained from 72.3% of the
study subjects.
Risk factors associated with chlamydial infection
Table 1 reveals the results of the univariate analysis and
features potential risk factors for chlamydial infection.
The overall prevalence of chlamydial infection was 18.4%
(95% confidence interval [95% CI] 17.3–19.5%). Preva-
lence for men and women were 16.7 % (95% CI 15.3–
18.0%) and 22.8% (95% CI 17.5–28.1%), respectively.
Age group-specific prevalences was 25.7% (95% CI 22.5–
28.9%) in < 20 year olds, 23.5% (95% CI 20.3–26.7%) in
20–24 year olds, 22.3% (95% CI 18.9–25.7%) in 25–30
year olds, and 11.5% (95% CI 10.3–12.7%) in > 30 year
olds. The prevalence of CT infection among asymptomatic
patients was 14.0% (95% CI 12.7–15.3%).
Patients that reported inconsistent condom use had a
higher risk for chlamydial infection than patients that
reported consistent condom use (P < 0.001). Patients that
were symptomatic at the time of testing were more often
CT positive than asymptomatic patients (P < 0.05).
Patients with N. gonorrhoeae infections had higher preva-
lence of CT infection than those who did not (P < 0.001).
There appeared to have been no significant difference
with regard to the incidence of infection amongst gender,
marital status, education level, and sexual orientation
(Table 1).
From the logistic regression model, aged ≤ 30 years
(adjusted odds ratio [AOR] = 2.44; 95% confidence inter-
val [CI] = 1.52–3.84; P < 0.001), inconsistent condom use
(AOR = 2.01; 95% CI = 1.32–3.06; P < 0.001), being
symptomatic at the time of testing (dysuria, urethral dis-
charge) (AOR = 1.84; 95% CI = 1.21–2.80; P < 0.001), and
Table 1: Demographic characteristics of 653 subjects by status of C. trachomatis infection, 2004 – 2005, Taiwan
Variables Chlamydia (+) Chlamydia (-) Totalb
N  =  1 2 0N  =  5 3 3N =  6 5 3
Gender
Male 79 (16.7) 394 (83.3) 473 (72)
Female 41 (22.8) 139 (77.2) 180 (28)
Age group (years)*
< 20 35 (25.7) 101 (74.3) 136 (21)
20–24 28 (23.5) 91 (76.5) 119 (18)
25–30 23 (22.3) 80 (77.7) 103 (16)
> 30 34 (11.5) 261 (88.5) 295 (45)
Marital status
Single 96 (19.6) 394 (80.4) 490 (75)
Married 24 (14.7) 139 (85.3) 163 (25)
Education (years)
≤ 12 36 (23.5) 117 (76.5) 153 (24)
> 12 84 (16.8) 416 (83.2) 500 (76)
Condom use**
Always use 49 (13.7) 309 (86.3) 358 (55)
Sometimes/never use 71 (24.1) 224 (75.9) 295 (45)
Clinical symptoms*
Asymptomatic 47(14.0) 288 (86.0) 335 (51)
Symptomatic 73 (23.0) 245 (77.0) 318 (49)
Burning urination** 28 (34.6) 53 (65.4) 81
Genital pain/swelling 16 (15.8) 85 (84.2) 101
Urethral discharge** 35 (37.2) 59 (62.8) 94
Lower abdominal pain 10 (38.5) 16 (61.5) 26
Genital skin rash/ulceration 11 (9) 96 (18) 107
Vaginal dischargea** 12 (35.3) 22 (64.7) 34
Sexual orientation
Heterosexual 107 (18.2) 480 (81.8) 587 (90)
Homosexual/bisexual 13 (20.0) 53 (80.0) 66 (10)
Laboratory diagnoses
N. gonorrhoeae** 30 (41.0) 43 (58.9) 73 (11)
T. vaginalis 4 (66.7) 2 (33.3) 6 (0.9)
T. pallidum 5 (13.5) 32 (86.5) 37 (6)
HIV 2 (25.0) 6 (75.0) 8 (1)
Note: Data are the number (%) of patients, except where noted; a only the female data were used. b Percentage in column; *P < 0.05 ; ** P < 0.001 
by Chi-square test.BMC Public Health 2007, 7:120 http://www.biomedcentral.com/1471-2458/7/120
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having N. gonorrhoeae infection (AOR = 3.82; 95% CI =
2.20–6.58) were significantly, independently and posi-
tively associated with the prevalence of chlamydial infec-
tion (Table 2).
Discussion
Our study identified a relatively high prevalence of
chlamydial infection (18.4% overall; range 17.3–19.5%)
among patients attending an STD or genitourinary clinic
in Taiwan. Risk factors found to be independently associ-
ated with chlamydial infection were young age (< 30 years
old), inconsistent condom use during sexual intercourse,
being symptomatic (dysuria, urethral discharge) at the
time of testing, and having gonococcal infection.
Prevalence estimates for Chlamydia range widely between
study populations in different settings. Healthcare settings
have higher prevalence estimates than population-based
studies [14]. In the USA, the prevalence of C. trachomatis
genital infections amongst sexually active young adults
aged 16 to 20 years is 4–17% [15], whereas in the UK [16],
the prevalence of C. trachomatis infection varies consider-
ably amongst different sub-populations (range 5–13%).
Our study' incidence of chlamydia infection in these set-
tings was relatively high.
The findings in this report are subject to at least three lim-
itations. Firstly, the study population was collected from a
high risk group. They may not be truly representative of all
people aged 17–50 years in Taiwan. Secondly, whilst our
STD and urology clinics probably represent the experi-
ences of other STD and urology clinics in the country, the
data derived from these clinics may not appropriately
reflect the sub-population of CT-infected Taiwanese
patients presenting at other community clinics. Third, the
methods for identify T. vaginalis are less than optimal.
However, to our knowledge, it is the first study to be con-
ducted among men and women in this part of the coun-
try.
Our study is consistent with those of a previous study [15]
which reported a strong association between chlamydia
infection and youthful age. Chlamydia was most com-
mon among men aged 18–24 years, as others have noted
[17,18]. Our study found that men aged ≤ 30 were two to
three times more likely to be infected with chlamydia than
those aged > 30 years, even after adjusting for urethral
symptoms and condom use at last instance of sexual inter-
course; age should factor significantly into determining
the most likely population of men to be infected with
Chlamydia.
Consistent with the previous findings [18], we also found
that combining patient self-report symptoms of infection
and inconsistent condom use during sex in the past 60
days could identify patients more likely to be infected and
could greatly enhance efforts to detect those men regard-
less of whether they seek care at an STD clinic. In clinical
practice, people with symptoms of infection or a history
of recent unprotected sex should receive diagnostic testing
for Chlamydia. Our data raise the question of whether cer-
tain groups of men without symptoms should be rou-
tinely tested by virtue of their attendance in the STD clinic.
Currently, there are no guidelines on how best to address
men who are asymptomatic, much less for men with no
symptoms of infection and who have no history of sexual
contact with an infected person.
Unsafe sex puts a woman at risk of both sexually transmit-
ted infections and unwanted pregnancy. In this study,
patients reporting inconsistent condom use had a higher
risk for chlamydial infection than those reporting consist-
ent condom use (AOR = 2.01; 95% CI = 1.32–3.06). These
results emphasise that consistent condom use could have
a major impact, much as it did in other countries [19,20].
Our study found that concurrent gonococcal infection
was significantly associated with chlamydal infection;
however, no significant association was found with other
STDs (syphilis, trichomoniasis) or HIV infection. One
possible explanation is the lower rate (1.2%) of HIV infec-
tion in our study population. Another possible explana-
tion for the lack of association between chlamydial
infection and other STDs is the high sensitivity of the
employed diagnostic C. trachomatis PCR assay. This partic-
ular assay is capable of detecting infections with very low
copy numbers of C. trachomatis. These infections would
Table 2: Risk factors for chlamydial infection by stepwise logistic regression analysis
Variables Adjusted Odds Ratio 95% CI
Young age (age ≤ 30 years) (yes/no) 2.44 1.52–3.84*
Inconsistent condom use (yes/no) 2.01 1.32–3.06*
Currently symptomatic (yes/no) 1.84 1.21–2.80*
N. gonorrhoeae infection (yes/no) 3.82 2.20–6.58*
CI, confidence interval; dependent variable was C. trachomatis (+)/C. trachomatis (-); Independent variables available in the model were young age 
(age ≤ 30 years) (yes/no), inconsistent condom use (yes/no), currently symptomatic (dysuria, urethral discharge) (yes/no), N. gonorrhoeae infection 
(yes/no). Only results of significant variables are presented. *P < 0.001.Publish with BioMed Central    and   every 
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not have been detected by other microbiological assays
[21].
Conclusion
Our study supports the validity of routine testing of all
patients with genital symptoms of CT infection and
patients who report unprotected sex, regardless of age.
While the cost-effectiveness of such an approach requires
further study, our study also supports consideration of
routine screening among men < 30 years who attend an
STD or genitourinary clinic. Our results highlight the
notion that the prevention of sexually transmitted disease,
including CT, should constitute an important public-
health program for Taiwan.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
KTC was the lead writer and coordinator of the manu-
script, and worked on content development. SCC coordi-
nated data analysis and wrote the background and
methods. CCC, LHL and LHT contributed to laboratory
work and wrote the results and discussion. All authors
read and approved the final manuscript.
Acknowledgements
We are grateful to the staff of the Taipei City STD Control Center and 
Center for Disease Control, Taiwan for their assistance with data collec-
tion and interviewing of study participants.
References
1. Stamm WE: Chlamydia trachomatis infection: progress and
problems.  J Infect Dis 1999, 179:S380-S383.
2. Fenton KA, Lowndes CM: Recent trends in the epidemiology of
sexually transmitted infections in the European Union.  Sex
Transm Infect 2004, 80:255-263.
3. World Health Organization: Prevention and control of sexually
transmitted infections: draft global strategy.   [ h t t p : / /
www.who.int]. (accessed November 2006)
4. Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K,
Fenton KA, Korovessis C, Macdowall W, Nanchahal K, Purdon S,
Field J: Sexual behaviour in Britain: partnerships, practices,
and HIV risk behaviours.  Lancet 2001, 358:1835-1842.
5. Klavs I, Rodrigues LC, Wellings K, Keše D, Hayes R: Prevalence of
genital Chlamydia trachomatis infection in the general popu-
lation of Slovenia: serious gaps in control.  Sex Transm Infect
2004, 80:121-123.
6. Stamm WE: Chlamydia trachomatis infections of the adult.  In
Sexually Transmitted Diseases 3rd edition. Edited by: Holmes KK, Spar-
ling PF, Mardh PA. New York: McGraw-Hill; 1999. 
7. Joyee AG, Thyagarajan SP, Reddy EV, Venkatesan C, Ganapathy M:
Genital chlamydial infection in STD patients: its relation to
HIV infection.  Indian J Med Microbiol 2005, 23:37-40.
8. World Health Organization: Global prevalence and incidence of
selected curable sexually transmissible diseases: overview
and estimates.  Geneva: WHO 2001.
9. Bavastrelli M, Midulla M, Rossi D, Salzano M, Calzolari E, Midulla C,
Sanguigni S, Torre A, Giardini O: Sexually active adolescents and
young adults: a high risk group for Chlamydia trachomatis
infection.  J Travel Med 1998, 5:57-60.
10. Miller KE: Diagnosis and Treatment of Chlamydia trachomatis
infection.  Am Fam Physician 2006, 73:1411-1416.
11. Yu MC, Li LH, Lu TH, Tang LH, Tsai CH, Chen KT: Aetiology of
sexually transmitted diseases (STDs) and comparison of
STD syndromes and aetiological diagnosis in Taipei, Taiwan.
Clin Microbiol Infect 2005, 11:914-918.
12. Schachter J: DFA, EIA, PCR, LCR and other technologies:
what tests should be used for diagnosis of chlamydial infec-
tions?  Immunol Invest 1997, 26:157-161.
13. Cockayne A: Treponema and Borrelia.  In Medical Microbiology
16th edition. Edited by: Greenwood D, Slack RCB, Peutherer JF. Edin-
burgh: Churchill Livingstone; 2002:p343-351. 
14. Adams EJ, Charlett A, Edmunds WJ, Hughes G: Chlamydia tracho-
matis in the United Kingdom: a systematic review and analy-
sis of prevalence studies.  Sex Transm Infect 2004, 80:354-362.
15. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs
MM, Cohen MS, Harris KM, Udry JR: Prevalence of chlamydial
and gonococcal infections among young adults in the Unites
States.  JAMA 2004, 291:2229-2236.
16. Jones K, Webb A, Mallinson H, Birley H: Outreach health adviser
in a community clinic screening programme improves man-
agement of genital chlamydia infection.  Sex Transm Infect 2002,
78:101-105.
17. Marrazzo JM, White CL, Krekeler B, Celum CL, Lafferty WE, Stamm
WE, Handfield HH: Community-based urine screening for
Chlamydia trachomatis with ligase chain reaction assay.  Ann
Intern Med 1997, 127:796-803.
18. LaMontagne DS, Fine DN, Marrazzo JM: Chlamydia trachomatis
infection in asymptomatic men.  Am J Prev Med 2003, 24:36-42.
19. Parish WL, Laumann EO, Cohen MS, Pan S, Zheng H, Hoffman I,
Wang T, Ng KH: Population-based study of chlamydail infec-
tion in China – a hidden epidemic.  JAMA 2003, 289:1265-1273.
20. Alam N, Rahman M, Gausia K, Yunus MD, Islam N, Chaudhury P,
Monira S, Funkhouser E, Vermund SH, Killewo J: Sexually transmit-
ted infections and risk factors among truck stand workers in
Dhaka, Bangladesh.  Sex Tranms Dis 2007, 34:99-103.
21. van Valkengoed IG, Morre SA, van den Brule AJ, Meijer CJ, Deville W,
Bouter LM, Boeke AJ: Low diagnostic accuracy of selective
screening criteria for asymptomatic Chlamydia trachomatis
infections in the general population.  Sex Transm Infect 2000,
76:375-380.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/7/120/pre
pub